CalciMedica, Inc. (CALC)
NASDAQ: CALC · Real-Time Price · USD
1.210
-0.010 (-0.82%)
At close: Nov 13, 2026, 4:00 PM EST
1.320
+0.110 (9.09%)
After-hours: Nov 13, 2026, 7:45 PM EST
CalciMedica Employees
CalciMedica had 15 employees as of June 30, 2026. The number of employees did not change compared to the same quarter last year. That makes CalciMedica the 39,236th largest employer in the world and 5,701st in the United States.
Employees
15
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,007,333
Market Cap
8.26M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 15 | 0 | - |
| Mar 31, 2026 | 16 | 1 | 6.67% |
| Dec 31, 2025 | 16 | 2 | 14.29% |
| Sep 30, 2025 | 15 | 2 | 15.38% |
| Jun 30, 2025 | 15 | 2 | 15.38% |
| Mar 31, 2025 | 15 | 2 | 15.38% |
| Dec 31, 2024 | 14 | 1 | 7.69% |
| Sep 30, 2024 | 13 | -1 | -7.14% |
| Jun 30, 2024 | 13 | -1 | -7.14% |
| Mar 31, 2024 | 13 | 1 | 8.33% |
| Sep 30, 2023 | 14 | 2 | 16.67% |
| Jun 30, 2023 | 14 | 2 | 16.67% |
| Mar 31, 2023 | 12 | 0 | - |
| Sep 30, 2022 | 12 | 0 | - |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| CytoMed Therapeutics | 42 |
| Vistagen Therapeutics | 41 |
| Longeveron | 38 |
| BioLineRx | 24 |
| IN8bio | 18 |
| Moleculin Biotech | 17 |
| Kiora Pharmaceuticals | 13 |
| Ensysce Biosciences | 10 |
CALC News
- 5 days ago - CalciMedica Reports Third Quarter 2026 Financial Results and Provides Clinical & Corporate Updates - GlobeNewsWire
- 12 days ago - CalciMedica to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference - GlobeNewsWire
- 2 months ago - CalciMedica to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewsWire
- 2 months ago - Calcimedica Inc trading halted, news pending - TheFly
- 2 months ago - CalciMedica to effect 1-for-5 reverse stock split - TheFly
- 2 months ago - CalciMedica Announces One-for-Five Reverse Stock Split - GlobeNewsWire
- 2 months ago - CalciMedica initiated with a Buy at Guggenheim - TheFly
- 3 months ago - CalciMedica announces FDA alignment on Phase 2b Auxora trial design - TheFly